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INTRODUCTION
Idiopathic orbital inflammation (IOI) is among the most frequent orbital diseases encountered by ophthalmologists. 1 IOI is a non-infectious inflammation of the orbital soft tissues for which no cause is found after local and systemic evaluation. 2 The term IOI refers to a collection of different entities, including idiopathic sclerosing orbital inflammation, 3 idiopathic granulomatous orbital inflammation, 4 dacryoadenitis 5 and orbital myositis, 6 which makes patients with IOI an inhomogeneous patient population.
IOI presents with various signs and symptoms of inflammation, most frequently pain, eyeball motility disturbances and proptosis. 2 Due to the orbital soft tissue swelling, IOI may mimic a neoplasm ('orbital pseudotumour' is the historical term for IOI). The clinical course of IOI ranges from mild and self-limiting to devastating orbital sclerosis with blindness. 2 IOI, as is indicated by the word 'idiopathic' in the disease name, is of unknown aetiology. Many case reports and series have highlighted possible etiological factors for IOI, including autoimmune diseases 7 and medications such as bisphosphonates, 8 lithium 9 and chemotherapeutics. 10 Retroperitoneal fibrosis is a systemic disease entity that is similar in many respects to IOI. 11 Ergot derivatives, 12 13 asbestos 14 and a genetic predisposition 15 have been reported as risk factors for retroperitoneal fibrosis.
To our knowledge, systematic research of the risk factors for IOI has not been previously conducted. In this caseecontrol study, we explore associations between a number of risk factors and IOI.
METHODS
This study was designed as a caseecontrol study.
Our patients came from three orbital clinics in The Netherlands between 2000 and 2006. Patients with IOI were identified by searching the hospital diagnosis database for ICD-9 code 376.1. ICD-9 code 376.0, which was primarily used for orbital infection, was excluded.
Patient records were reviewed, and patients with all of the following three criteria were included in the study: (1) a clinical picture of orbital inflammation with either no improvement after antibiotic therapy and prompt improvement after systemic prednisone, or non-specific inflammation after an orbital tissue biopsy; (2) no local or systemic identifiable cause of the inflammation; and (3) age 18 or older and residing in The Netherlands. For example, sarcoidosis, lupus and Wegener granulomatosis were excluded as causes of IOI. Only patients who had had a first episode of IOI were included in the study. The localisation of IOI was determined by reviewing radiology images and was categorised as localised myositis, localised dacryoadenitis or diffuse inflammation. Histology reports, when available, were reviewed and classified as classic, sclerosing or granulomatous inflammation. 7 Laterality andcorticosteroid treatment were recorded.
For the controls, adults who had had a first episode of a rhegmatogenous retinal detachment (RD) were identified using the hospital surgical database. For each patient with IOI, we randomly selected four controls who had been diagnosed as having RD in the same hospital and in the same year and month as the patient. Hospital-based controls were chosen for availability, similar geographic area, high response rate and similar recollection of information. These controls were considered to be a good representation of the study base. Moreover, rhegmatogenous RD was considered to be of mechanical aetiology and expected to share none or few aetiological factors with IOI.
Institutional review board approval was given for this study, which adhered to the tenets of the Declaration of Helsinki.
A six-page questionnaire was sent to all patients and controls. The questionnaire collected information on sex, age at diagnosis, body mass index (BMI) at diagnosis, smoking status (current, former, never), pack years of smoking, diabetes (yes/no) and average number of days with flu or colds per year. Socioeconomic status was determined by the highest educational level of the participant (primary school, secondary school, professional education, higher education) and, when the information was available, by the highest educational level of the participant's partner. To determine whether an autoimmune disease was or had been present, participants were asked to describe prior inflammation of the orbit, muscles, joints, skin, connective tissue, neural tissue, intestines, kidneys, lungs and/or thyroid up to the time of the questionnaire. An immunologist determined whether the self-reported inflammation was consistent with autoimmune disease.
The following questions were asked about the 2 years preceding the diagnosis of RD or IOI, all defined as yes/no variables: any occurrence of blunt trauma to the orbit; any surgery of the orbit, sinuses or facial bones; any use of bisphosphonates, ergot derivatives, lithium, chemotherapy or thyroid hormones; any exposure to asbestos or lysergic acid diethylamide (LSD); or any reported physical or emotional distress. In addition, participants were asked if any siblings, parents or grandparents had ever had any orbital inflammatory disease, lupus, thyroiditis, myasthenia gravis, uveitis or diabetes mellitus. Women were asked about the number of pregnancies, age at birth of their first child, use of oral contraceptives or hormone-replacement therapy during the 2 years preceding diagnosis, menopausal status at disease development and age at menopause, if applicable. A time period of 2 years before the onset of the disease was chosen for adequate recall and to look at relative short-term effects of potential aetiological factors.
One reminder was sent to participants who did not respond to the first request. The response forms were checked for sex and age to identify forms that were not filled out by the intended individual. Nonmatching forms were excluded.
Response forms were entered into a database and analysed using statistical software (SPSS for Windows 15.0 (SPSS, Chicago, Illinois) and R 2.6.0 for Windows, R Development).
Characteristics of responders and non-responders were compared. Continuous variables were categorised into tertiles. Using complete case analysis, ORs and accompanying 95% CIs were computed to describe the associations between risk factors and the occurrence of IOI. Multivariate analysis was performed using binary logistic regression to adjust relationships for age (continuous), sex, tertiles of socio-economic status, pack-year tertiles of smoking and blunt orbital trauma because adjustment for these variables changed the ORs more than 10%.
Multivariate analysis was repeated on a multiple imputed dataset to obtain more precise and valid measures of association for variables with missing values. 16 Multiple imputation was chosen because of its wide applicability to almost any statistical situation. 17 The pattern of missing values was evaluated and considered missing at random. For each missing value, 10 imputations were performed using between six and 19 bestcorrelated variables, including the outcome. 18 Imputation was carried out in R (with the aregImpute function in library 'Hmisc').
RESULTS
Questionnaires were sent by mail to 103 patients and 410 controls. Two questionnaires to controls under the age of 18 were not sent because of their age. Sixty-nine patients (67%) and 295 controls (72%) returned the questionnaires after two mailings. Of the non-responders, 16 (all controls) had died, and 16 (four patients; 12 controls) had moved without providing a new address. Patients who responded were somewhat older than patients who did not respond (average age, 52.6 years vs 49.0 years) (table 1). Response rates of patients and controls differed somewhat between clinics (patients from clinic B responded less) and between years of diagnosis (controls diagnosed between 2002 and 2003 responded less).
The patients with IOI were categorised as follows: 17 with isolated myositis, 19 with isolated dacryoadenitis and 33 with diffuse inflammation. Biopsies showed classic inflammation in 21, sclerosing in eight and granulomatous in two patients. Five patients had bilateral orbital involvement. Fifty-one patients were treated with corticosteroids.
The mean (SD) age at diagnosis of the patients with IOI was 52.6 (13.4) years. For controls with RD, the mean (SD) age was 59.6 (11.8) years. The male-to-female ratio was 2:3 in patients with IOI and 7:4 in controls with RD.
Potential risk factors for IOI are described for patients and for controls. Patients with IOI were younger, more often female and of lower socio-economic status. In the multivariate analysis, we 
COMMENT
In this study, risk factors for the development of IOI are evaluated by comparing patients with IOI to controls with RD. We found a significant association between IOI and sex (female), age (younger), socio-economic status (lower), BMI (higher), use of bisphosphonates and age at birth of first child (younger). The association between autoimmune disease and IOI was almost statistically significant.
In the IOI group, there were relatively more females (61%) than in the RD group (39%), and the patients with IOI were, on average, 7 years younger than the controls with RD (mean age 53 and 60 years, respectively). These differences highlight the different demographic features of IOI and RD, where RD is associated with male sex and older age. 19 We used the highest level of education of the patient and of their partner as a surrogate variable for socio-economic status. RD has been associated with a lower education level (education beyond age 16 years: OR 0.6; 95% CI 0.3 to 1.1). 19 This association may be explained by ocular trauma as a cause of RD (10% in a large survey of RD 20 ; it was 6% in our study), and a higher risk of ocular trauma in craftsmen. However, in our study, we found lower educational levels to be associated with IOI as well, even after adjusting for ocular trauma.
As is known from clinical practice, a higher BMI was associated with IOI. The BMI was calculated from height and weight at diagnosis of IOI and, therefore, should not have been affected by the use of corticosteroids. The relation between metabolic regulation and the immune system has been of interest in recent research. Obesity is associated with a chronic inflammatory response. In obesity, the inflammatory response appears to be triggered and reside predominantly in adipose tissue. The high orbital fat content in obese patients may explain why inflammatory diseases occur in the orbit. 21 Leptin is thought to be central to the link between obesity and autoimmunity because leptin is secreted by adipocytes and can trigger the production of proinflammatory and pathogenic cytokines. 22 The cases of three patients who developed IOI after administration of intravenous bisphosphonates have been reported. 8 23 The proposed mechanism of action is the release of the inflammatory cytokines IL-1 and IL-6 triggered by bisphosphonates. The prevalence of bisphosphonate use in the population is low (it was 2.8% in our study). Therefore, the association between bisphophonate use and IOI will not have major clinical consequences.
We decided to look at the role of female hormones in IOI because of the intimate relationship between hormones and the immune system. Oestrogens are implicated as enhancers of humoural immunity, and androgens and progesterone are natural immune suppressors. 24 25 We looked for higher oestrogen levels in patients with IOI, which is suggested by a small female predilection and higher age at menopause. 24 However, the observation of a lower number of pregnancies in patients with IOI, when oestrogens are high, does not support an aetiological role of high oestrogens in IOI. The statistically significant association between the lower age at first childbirth and IOI suggests that female hormones play a role in IOI, but it is not clear how this relates to oestrogens and progesterone. Lower age at first childbirth may also be a risk indicator of risk factor clustering, as occurs with breast cancer. 26 An association between IOI and autoimmune diseases was postulated by Mombaerts and Koornneef, 27 who found that 10% of patients with IOI had a concurrent autoimmune disease. We found concurrent autoimmune diseases in 12% of patients with IOI (OR 2.56; 95% CI 0.93 to 7.05). Although the association was not statistically significant, it is suggestive of an autoimmune pathogenesis in IOIA genetic predisposition, or a disregulated immune system with autoantibodies against multiple self-antigens could explain the high co-occurrence of IOI with autoimmune diseases.
Of the proposed possible risk factors, we did not find an association between IOI and ergot derivatives, lithium, LSD, chemotherapy, asbestos, trauma or family history. The equal number of days patients with IOI and controls with RD had flu or colds suggests that they had similar immune system functioning.
A caseecontrol study is implicitly limited in that only associations can be described, but no causality inferred. The quality of such a study is highly dependent on the selection of controls. In this study, it is not possible to draw conclusions about common risk factors between IOI and RD. Because RD is caused by posterior vitreous detachment, we thought RD unlikely to be associated with risk factors other than age, sex and ocular trauma. We did not use a control group of healthy volunteers because we expected an unacceptable low response rate. A cohort design was considered inefficient because of the long inclusion time of 7 years.
By selecting all patients with IOI (some who were not histologically confirmed), we have selected a heterogeneous group of diseases. This will likely dilute associations of risk factors that are specific for subgroups like dacryoadenitis and myositis. However, the sample size is too low for subgroup analysis. Limiting the study to histologically confirmed patients would have introduced a selection bias and would have yielded a lower number of cases.
Recall bias due to the retrospective nature of this study was considered to have influenced both patients and controls in equal amounts. The effect of missing values was evaluated by using yp Values calculated using the c
